Acceptance of short course artesunate plus mefloquine drug combination by malaria patients in rural Myanmar.
A cross sectional study was carried out in a rural area of Myanmar to identify malaria patients' acceptance of artesunate plus mefloquine drug combination and to determine the cost borne by patients. The majority (88.5%) preferred this new regimen rather than the other ones they had used before; conviction of drug efficacy was the reason given for the preference by most of them. Traveling on foot to rural health centers or a health assistant's residence for getting the drugs was found to be the main route. Average cost incurred by a patient to get the drug was found to be 274.22 Kyats. Among the cost items, drug cost was the highest item that they had used.
Win
L L
LL
Department of Medical Research, Ministry of Health, Myanmar.
Shwe
T
T
Lwin
M
M
Aung
S
S
Zaw
A K
AK
Mar
K K
KK
D000293:Adolescent; D000328:Adult; D000368:Aged; D000962:Antimalarials / Q000191:economics / Q000627:therapeutic use*; D037621:Artemisinins; D000077332:Artesunate; D003430:Cross-Sectional Studies; D004338:Drug Combinations; D005260:Female; D017048:Health Care Costs; D006801:Humans; D016778:Malaria, Falciparum / Q000188:drug therapy* / Q000191:economics / Q000453:epidemiology; D008297:Male; D015767:Mefloquine / Q000191:economics / Q000627:therapeutic use*; D008875:Middle Aged; D002052:Myanmar / Q000453:epidemiology; D010349:Patient Compliance; D012424:Rural Population; D012717:Sesquiterpenes / Q000191:economics / Q000627:therapeutic use*
D000962:Antimalarials; D037621:Artemisinins; D004338:Drug Combinations; D012717:Sesquiterpenes; D000077332:Artesunate; D015767:Mefloquine